Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Serotonin reuptake transporter (SERT) plays a critical role in the onset of fructose-induced hepatic steatosis in mice.

Haub S, Kanuri G, Volynets V, Brune T, Bischoff SC, Bergheim I.

Am J Physiol Gastrointest Liver Physiol. 2010 Mar;298(3):G335-44. doi: 10.1152/ajpgi.00088.2009. Epub 2009 Aug 27.

2.

Effect of tryptophan supplementation on diet-induced non-alcoholic fatty liver disease in mice.

Ritze Y, Bárdos G, Hubert A, Böhle M, Bischoff SC.

Br J Nutr. 2014 Jul 14;112(1):1-7. doi: 10.1017/S0007114514000440. Epub 2014 Apr 8.

PMID:
24708895
3.

Metformin protects against the development of fructose-induced steatosis in mice: role of the intestinal barrier function.

Spruss A, Kanuri G, Stahl C, Bischoff SC, Bergheim I.

Lab Invest. 2012 Jul;92(7):1020-32. doi: 10.1038/labinvest.2012.75. Epub 2012 Apr 23.

4.

Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice.

Spruss A, Kanuri G, Wagnerberger S, Haub S, Bischoff SC, Bergheim I.

Hepatology. 2009 Oct;50(4):1094-104. doi: 10.1002/hep.23122.

PMID:
19637282
5.

Protective effect of bile acids on the onset of fructose-induced hepatic steatosis in mice.

Volynets V, Spruss A, Kanuri G, Wagnerberger S, Bischoff SC, Bergheim I.

J Lipid Res. 2010 Dec;51(12):3414-24. doi: 10.1194/jlr.M007179. Epub 2010 Sep 16.

6.

Serotonin receptor type 3 antagonists improve obesity-associated fatty liver disease in mice.

Haub S, Ritze Y, Ladel I, Saum K, Hubert A, Spruss A, Trautwein C, Bischoff SC.

J Pharmacol Exp Ther. 2011 Dec;339(3):790-8. doi: 10.1124/jpet.111.181834. Epub 2011 Sep 8.

7.

Role of the inducible nitric oxide synthase in the onset of fructose-induced steatosis in mice.

Spruss A, Kanuri G, Uebel K, Bischoff SC, Bergheim I.

Antioxid Redox Signal. 2011 Jun;14(11):2121-35. doi: 10.1089/ars.2010.3263. Epub 2011 Mar 16.

PMID:
21083420
8.

Toll-like receptors 1-9 are elevated in livers with fructose-induced hepatic steatosis.

Wagnerberger S, Spruss A, Kanuri G, Volynets V, Stahl C, Bischoff SC, Bergheim I.

Br J Nutr. 2012 Jun;107(12):1727-38. doi: 10.1017/S0007114511004983. Epub 2011 Oct 10.

PMID:
22018861
9.

Role of tumor necrosis factor α (TNFα) in the onset of fructose-induced nonalcoholic fatty liver disease in mice.

Kanuri G, Spruss A, Wagnerberger S, Bischoff SC, Bergheim I.

J Nutr Biochem. 2011 Jun;22(6):527-34. doi: 10.1016/j.jnutbio.2010.04.007. Epub 2010 Aug 30.

PMID:
20801629
10.

Fructose-induced steatosis in mice: role of plasminogen activator inhibitor-1, microsomal triglyceride transfer protein and NKT cells.

Kanuri G, Spruss A, Wagnerberger S, Bischoff SC, Bergheim I.

Lab Invest. 2011 Jun;91(6):885-95. doi: 10.1038/labinvest.2011.44. Epub 2011 Mar 21.

11.

Role of serotonin in fatty acid-induced non-alcoholic fatty liver disease in mice.

Ritze Y, Böhle M, Haub S, Hubert A, Enck P, Zipfel S, Bischoff SC.

BMC Gastroenterol. 2013 Dec 9;13:169. doi: 10.1186/1471-230X-13-169.

12.

Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin.

Bergheim I, Weber S, Vos M, Krämer S, Volynets V, Kaserouni S, McClain CJ, Bischoff SC.

J Hepatol. 2008 Jun;48(6):983-92. doi: 10.1016/j.jhep.2008.01.035. Epub 2008 Mar 14.

PMID:
18395289
13.

Reduced serotonin reuptake transporter (SERT) function causes insulin resistance and hepatic steatosis independent of food intake.

Chen X, Margolis KJ, Gershon MD, Schwartz GJ, Sze JY.

PLoS One. 2012;7(3):e32511. doi: 10.1371/journal.pone.0032511. Epub 2012 Mar 8.

14.
15.

Oral Glutamine Supplementation Protects Female Mice from Nonalcoholic Steatohepatitis.

Sellmann C, Jin CJ, Degen C, De Bandt JP, Bergheim I.

J Nutr. 2015 Oct;145(10):2280-6. doi: 10.3945/jn.115.215517. Epub 2015 Aug 5.

16.

Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake.

Thuy S, Ladurner R, Volynets V, Wagner S, Strahl S, Königsrainer A, Maier KP, Bischoff SC, Bergheim I.

J Nutr. 2008 Aug;138(8):1452-5.

17.

Activation of farnesoid X receptor (FXR) protects against fructose-induced liver steatosis via inflammatory inhibition and ADRP reduction.

Liu X, Xue R, Ji L, Zhang X, Wu J, Gu J, Zhou M, Chen S.

Biochem Biophys Res Commun. 2014 Jul 18;450(1):117-23. doi: 10.1016/j.bbrc.2014.05.072. Epub 2014 May 27.

18.

Lactobacillus casei Shirota protects from fructose-induced liver steatosis: a mouse model.

Wagnerberger S, Spruss A, Kanuri G, Stahl C, Schröder M, Vetter W, Bischoff SC, Bergheim I.

J Nutr Biochem. 2013 Mar;24(3):531-8. doi: 10.1016/j.jnutbio.2012.01.014. Epub 2012 Jun 27.

PMID:
22749137
19.

Role of serotonin in intestinal inflammation: knockout of serotonin reuptake transporter exacerbates 2,4,6-trinitrobenzene sulfonic acid colitis in mice.

Bischoff SC, Mailer R, Pabst O, Weier G, Sedlik W, Li Z, Chen JJ, Murphy DL, Gershon MD.

Am J Physiol Gastrointest Liver Physiol. 2009 Mar;296(3):G685-95. doi: 10.1152/ajpgi.90685.2008. Epub 2008 Dec 18.

20.

Enteropathogenic Escherichia coli infection inhibits intestinal serotonin transporter function and expression.

Esmaili A, Nazir SF, Borthakur A, Yu D, Turner JR, Saksena S, Singla A, Hecht GA, Alrefai WA, Gill RK.

Gastroenterology. 2009 Dec;137(6):2074-83. doi: 10.1053/j.gastro.2009.09.002. Epub 2009 Sep 10.

Supplemental Content

Support Center